Tissue Regenix Group Share Price | |
---|---|
Price | 61.50 |
Bid | 61.00 |
Ask | 62.00 |
Change | -1.30 (-2.11%) |
Volume | 47,682 |
Open | 61.50 |
High | 61.50 |
Low | 60.20 |
Prev. Close | 61.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £42.49m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 0.605 |
52 Week Low Date | 27-Apr-2023 |
# Trades | 10 |
---|---|
Vol. Sold | 10,482 |
Sold Value | £6.40k |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -31.54169 |
Earnings | -1.908585 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 16:35:16 | 60.20 | 3 | Sell* | 61.00 | 62.00 | 1.81 | UT Uncrossing Trade |
24-Apr-24 | 16:20:50 | 61.48 | 1 | Sell* | 61.00 | 62.00 | 0.61 | O Ordinary |
24-Apr-24 | 12:31:36 | 61.00 | 25,000 | Unknown* | 61.00 | 62.00 | 15.25k | O Ordinary Delayed publication |
24-Apr-24 | 14:00:04 | 60.20 | 14 | Sell* | 61.00 | 62.00 | 8.43 | UT Uncrossing Trade |
24-Apr-24 | 12:42:35 | 61.00 | 12,200 | Unknown* | 61.00 | 62.00 | 7,442 | O Ordinary Delayed publication |
24-Apr-24 | 12:45:36 | 61.00 | 2,300 | Sell* | 61.00 | 62.00 | 1,403 | O Ordinary |
24-Apr-24 | 12:40:48 | 61.00 | 178 | Sell* | 61.00 | 62.00 | 108.58 | O Ordinary |
24-Apr-24 | 12:30:49 | 61.00 | 365 | Sell* | 61.00 | 62.00 | 222.65 | O Ordinary |
24-Apr-24 | 10:25:31 | 61.38 | 1,621 | Sell* | 61.00 | 62.00 | 994.97 | O Ordinary |
24-Apr-24 | 08:46:25 | 61.05 | 6,000 | Sell* | 61.00 | 62.00 | 3,663 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.56 | GBX | 928,570 | 8,690,770 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.57 | GBX | 500,000 | 8,690,770 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.